Cell Killing And Resistance In Pre-Operative Breast Cancer Chemotherapy

April 2017

Cancer

Country of origin: USA

Despite the recent development of technologies giving detailed images of tumours in vivo, direct or indirect ways to measure how many cells are actually killed by a treatment or are resistant to it are still beyond our reach.

Researchers designed a simple model of tumour progression during treatment, based on descriptions of the key phenomena of proliferation, quiescence, cell killing and resistance, and giving as output the macroscopically measurable tumour volume and growth fraction. The model was applied to a database of the time course of volumes of breast cancer in patients undergoing pre-operative chemotherapy, for which the initial estimate of proliferating cells by the measure of the percentage of Ki67-positive cells was available.

The analysis recognises different patterns of response to treatment. In one subgroup of patients the fitting implied drug resistance. In another subgroup there was a shift to higher sensitivity during the therapy. In the subgroup of patients where killing of cycling cells had the highest score, the drugs showed variable efficacy against quiescent cells.

The research concludes that the approach was feasible, providing items of information not otherwise available. Additional data, particularly sequential Ki67 measures, could be added to the system, potentially reducing uncertainty in estimates of parameter values.

The complete article is available as a provisional PDF.

Resources

Cancer statistics: availability and location July 2018 Document aims to provide an overview about cancer statistics, including information on statistics publicly available and...
inPractice® Oncology July 2018 inPractice® Oncology is the only point-of-care clinical reference designed to meet the unique needs of specialists. Full...
Cancer Research Network Measures March 2018 Following a period of consultation Cancer Research Network Measures have been issued by the Department of Health as part of...
Orlive Surgical Broadcasts February 2018 Orlive is a trusted world resource in surgical broadcasting for physians, surgeons and caregivers.
Cancer.net mobile by ASCO January 2018 The Cancer.net mobile app by ASCO provides info on 120 types of cancer, including treatment information, managing side...
Chemo Calendar January 2018 Chemo Calendar app by Health Monitor Network can track the patient’s symptoms. It captures key symptoms like temperature,...
Cancer Navigator January 2018 Cancer Navigator app was developed by MD Acuity, LLC. The app tracks symptoms during cancer treatment in a graphic...
Oncology Nurse Advisor January 2018 Oncology Nurse Advisor is a free, simple to use, medical app that offers oncology nurses the latest news and trends....
Breast Cancer Survivor January 2018 Survivorship encompasses a range of lifestyle approaches to improve wellbeing and survival after a diagnosis of cancer....
Cancer Emergency Response Tool January 2018 The Cancer Emergency Response Tool (CERT) allows cancer patients to rapidly and effectively manage chemotherapy toxicity...
Search by Keyword